Yang Ke

Executive Vice President

Institution
Peking University

Country
China

Field
Leadership

Yang, the executive vice president of Peking University, won the 2015 Prince Mahidol Award for reforming research and medical education in China.

(Photo: Peking University)


Related articles

The Age Of The Astropreneur Is Here

As space becomes increasingly democratised, even small companies in small countries can get in on the game, says Dr Bidushi Bhattacharya, CEO and co-founder of Singapore-based space tech incubator Astropreneurs HUB.

Alibaba Launches First AI Research Institute Outside Of China

NTU Singapore and Alibaba Group have launched a joint research institute for developing artificial intelligence technologies.

Nanoparticles Make Pesticide Detection Super Sensitive

Using polystyrene coated magnetic nanoparticles, scientists in Singapore were able to detect trace amounts of pesticide on vegetables in less than two hours.

EmTech Asia Announces 2018’s Innovators Under 35

Ten individuals from Singapore, Australia and Taiwan have been selected as finalists for MIT Technology Review’s Innovators Under 35 program.

Singapore Honors Top Scientific Talent

Eight research scientists and engineers in Singapore were honored this evening at the Republic's 2013 President’s Science and Technology Awards.

China Launches Its Own Million Dollar ‘Nobel’ Prize

From 2017, the privately funded Future Science Awards will recognize the achievements of Chinese scientists in the life sciences and materials science.

Process And Store Memory In A Single Chip

In the future, data could be processed where it is stored, paving the way for thinner, smaller computers and mobile devices.

Soup Up Your Battery With Some Seaweed

Seaweed-derived nanofibers could be an environmentally-friendly way to improve the performance of batteries, superconductors and fuel cells.

Promising Dengue Vaccine Faces Final Test

The TV003 vaccine, which researchers believe will protect against all four strains of dengue, is set to complete a phase III trial by 2018.